• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBSEBIO:LX

485.00 USD 6.62 1.38%

As of 00:59:30 ET on 10/17/2014.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBSEBIO)

Year To Date: +20.94% 3-Month: +11.21% 3-Year: +36.39% 52-Week Range: 351.05 - 517.04
1-Month: -4.43% 1-Year: +28.38% 5-Year: +24.10% Beta vs NSESWRLD: 0.89

Mutual Fund Chart for UBSEBIO

No chart data available.
  • UBSEBIO:LX 485.00
  • 1M
  • 1Y
Interactive UBSEBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBSEBIO

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: 10-15-1996 Telephone: 352-44-10-10-1 Tel
Managers: ANGUS W H MUIRHEAD / NATHALIE LOTSCHER PETRUS
Web Site: www.ubs.com

Fundamentals for UBSEBIO

NAV (on 2014-10-17) 485.00
Assets (M) (on 2014-10-17) 1,123.80
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for UBSEBIO

No dividends reported

Fees & Expenses for UBSEBIO

Front Load -
Back Load 2.00
Current Mgmt Fee 1.63
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.08

Top Fund Holdings for UBSEBIO

Filing Date: 05/30/2014
Name Position Value % of Total
Biogen Idec Inc 305,700 97,631,409 10.076%
Gilead Sciences Inc 1,108,500 90,021,285 9.291%
Amgen Inc 750,114 87,005,723 8.979%
Celgene Corp 975,520 74,641,913 7.703%
Medivation Inc 660,000 48,067,800 4.961%
Alexion Pharmaceuticals Inc 281,300 46,785,816 4.829%
Regeneron Pharmaceuticals Inc 150,200 46,105,392 4.758%
BioMarin Pharmaceutical Inc 781,100 45,272,556 4.672%
Vertex Pharmaceuticals Inc 606,100 43,796,786 4.520%
Incyte Corp 811,000 40,185,050 4.147%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil